Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SHOC2–MRAS–PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis
Lucy C. Young, Nicole Hartig, Isabel Boned del Río, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 45
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

RAS-targeted therapies: is the undruggable drugged?
Amanda R. Moore, Scott Rosenberg, Frank McCormick, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 533-552
Open Access | Times Cited: 819
Evidence for 28 genetic disorders discovered by combining healthcare and research data
Joanna Kaplanis, Kaitlin E. Samocha, Laurens Wiel, et al.
Nature (2020) Vol. 586, Iss. 7831, pp. 757-762
Open Access | Times Cited: 499
KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
Timothy H. Tran, Albert H. Chan, Lucy C. Young, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 191
Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients
Jianzhu Ma, Samson Fong, Yunan Luo, et al.
Nature Cancer (2021) Vol. 2, Iss. 2, pp. 233-244
Open Access | Times Cited: 136
The RASopathies: from pathogenetics to therapeutics
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 117
Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers
Martha Dillon, Antonio R. Lopez, Edward H. Lin, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5059-5059
Open Access | Times Cited: 107
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS
Yuta Adachi, Ryo Kimura, Kentaro Hirade, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 829-843
Closed Access | Times Cited: 47
The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases
Liang Qu, Chao Pan, Shiming He, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 76
Structure–function analysis of the SHOC2–MRAS–PP1C holophosphatase complex
Jason J. Kwon, Behnoush Hajian, Yuemin Bian, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 408-415
Open Access | Times Cited: 58
The molecular genetics of RASopathies: An update on novel disease genes and new disorders
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43
Navigating the ERK1/2 MAPK Cascade
Ana Martín-Vega, Melanie H. Cobb
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1555-1555
Open Access | Times Cited: 37
The small GTPase MRAS is a broken switch
Gabriela Bernal Astrain, Regina Strakhova, Chang Hwa Jo, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers
Greg G. Jones, Isabel Boned del Río, Sibel Sarı, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 68
Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome
Yline Capri, Elisabetta Flex, Oliver H.F. Krumbach, et al.
The American Journal of Human Genetics (2019) Vol. 104, Iss. 6, pp. 1223-1232
Open Access | Times Cited: 64
Accessory proteins of the RAS-MAPK pathway: moving from the side line to the front line
Silke Pudewell, Christoph Wittich, Neda S. Kazemein Jasemi, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 52
Advancing RAS/RASopathy therapies: An NCI‐sponsored intramural and extramural collaboration for the study of RASopathies
Andrea M. Gross, Megan N. Frone, Karen W. Gripp, et al.
American Journal of Medical Genetics Part A (2020) Vol. 182, Iss. 4, pp. 866-876
Open Access | Times Cited: 50
Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome
Daniel A. Bonsor, Patrick Alexander, Kelly Snead, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 10, pp. 966-977
Open Access | Times Cited: 37
Structure of the MRAS–SHOC2–PP1C phosphatase complex
Zachary J. Hauseman, Michelle Fodor, Anxhela Dhembi, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 416-423
Open Access | Times Cited: 31
Structural basis for SHOC2 modulation of RAS signalling
Nicholas P. D. Liau, Matthew C. Johnson, Saeed Izadi, et al.
Nature (2022) Vol. 609, Iss. 7926, pp. 400-407
Open Access | Times Cited: 30
Cryo-EM structure of a RAS/RAF recruitment complex
Eunyoung Park, Shaun Rawson, Anna M. Schmoker, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Uncovering a membrane-distal conformation of KRAS available to recruit RAF to the plasma membrane
Que N. Van, César A. López, Marco Tonelli, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 39, pp. 24258-24268
Open Access | Times Cited: 47
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics
Isabel Boned del Río, Lucy C. Young, Sibel Sarı, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 27, pp. 13330-13339
Open Access | Times Cited: 46
Integrating healthcare and research genetic data empowers the discovery of 28 novel developmental disorders
Joanna Kaplanis, Kaitlin E. Samocha, Laurens Wiel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 43
The Role of R-Ras Proteins in Normal and Pathologic Migration and Morphologic Change
Shannon M. Weber, Steven L. Carroll
American Journal Of Pathology (2021) Vol. 191, Iss. 9, pp. 1499-1510
Open Access | Times Cited: 35
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
Sisi Chen, Rahul S. Vedula, Antonio Cuevas-Navarro, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2434-2453
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top